Pendulum

Pendulum (pendulumlife.com) is a consumer microbiome company that formulates and sells probiotic and prebiotic supplements aimed at gut health, metabolic function, and blood glucose management. Its direct-to-consumer catalog includes Metabolic Daily, a five-strain "4-in-1" daily probiotic containing live Akkermansia positioned for gut health, metabolism, mood and energy ($49); an Akkermansia product marketed for gut lining support and reduced gut permeability ($54); Glucose Control, described as a medical probiotic for the nutritional management of type 2 diabetes ($99); Polyphenol Booster, a polyphenol supplement intended to feed the probiotic strains ($35); a Metabolic Daily Bundle combining the flagship probiotic and polyphenols ($74); and Gut Fuel, a mix-in prebiotic fiber and polyphenol supplement sold in pouch and single-serve packet formats ($40 each).

The company states it was founded by PhD-level doctors and scientists trained at Johns Hopkins, Harvard, Berkeley and Stanford, and that it manufactures next-generation anaerobic strains in its own oxygen-free facility in the United States. It positions Glucose Control as the only medical probiotic clinically shown to improve A1C in type 2 diabetes, and highlights live Akkermansia as a proprietary "keystone" strain referenced in more than 3,000 scientific publications. Pendulum describes the Mayo Clinic as its first investor and an ongoing research partner, and says it is the first consumer microbiome company to co-develop a registry with the Mayo Clinic. Company materials also note team involvement with American Diabetes Association chapters and the ADA Research Foundation, and that Pendulum was profiled at the ADA's annual Scientific Sessions.

Founding story

Company materials state Pendulum was founded by PhD doctors and scientists from Johns Hopkins, Harvard, Berkeley and Stanford, and that the Mayo Clinic was its first investor and remains a research partner. Founding date and founder names are not stated in the available sources.

Business model

Direct-to-consumer e-commerce: Pendulum sells branded supplements at listed per-unit prices through its own website, with bundles, a subscription/recurring-order system with customer accounts, and a referral discount program (30% off a first order with a $30 minimum). Products are marketed as FSA/HSA eligible through a third-party partner, Burst, which issues letters of medical necessity from licensed providers to support reimbursement of up to 40-100% using pre-tax funds.

Product sales of probiotic, prebiotic and polyphenol supplements priced from $35 to $99 per item, sold individually, in bundles, and via recurring subscriptions.

Traction

Public evidence of traction is limited to the company's own site: an active e-commerce operation with multiple product lines, subscription infrastructure, customer and clinician testimonials, and stated Mayo Clinic and American Diabetes Association affiliations. No revenue, customer count or funding figures are disclosed in the sources reviewed.

Latest developments

The company markets a reformulated version of its flagship Metabolic Daily probiotic (described as "new + improved") and offers FSA/HSA reimbursement on purchases through the partner Burst.